CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-28 | Quart Barry D Director | Option exercise · Share Option 10b5-1 | −13,099 | 13,237 | ||
| 2026-04-09 | Moat Ross CHIEF OPERATING OFFICER | Sale 10b5-1 | −1,703 | $46.69 | $80K | 12,029 |
| 2026-04-09 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −6,625 | $46.69 | $309K | 27,418 |
| 2026-04-07 | Tessari Eben CHIEF STRATEGY OFFICER | Option exercise | +2,726 | 23,976 | ||
| 2026-04-07 | Tessari Eben CHIEF STRATEGY OFFICER | Shares withheld for taxes | −846 | $48.94 | $41K | 23,130 |
| 2026-04-07 | Tessari Eben CHIEF STRATEGY OFFICER | Option exercise · Restricted Share Unit | −2,726 | 0 | ||
| 2026-04-07 | Moat Ross CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +2,477 | 14,506 | ||
| 2026-04-07 | Moat Ross CHIEF OPERATING OFFICER | Shares withheld for taxes 10b5-1 | −774 | $48.94 | $38K | 13,732 |
| 2026-04-07 | Moat Ross CHIEF OPERATING OFFICER | Option exercise · Restricted Share Unit 10b5-1 | −2,477 | 0 | ||
| 2026-04-07 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise | +2,694 | 17,457 | ||
| 2026-04-07 | Ragosa Mark CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −1,303 | $48.94 | $64K | 16,154 |
| 2026-04-07 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Restricted Share Unit | −2,694 | 0 | ||
| 2026-04-07 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise | +2,497 | 66,831 | ||
| 2026-04-07 | Paolini John F. CHIEF MEDICAL OFFICER | Shares withheld for taxes | −1,208 | $48.94 | $59K | 65,623 |
| 2026-04-07 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Restricted Share Unit | −2,497 | 0 | ||
| 2026-04-07 | Patel Sanj K CHAIRMAN & CEO | Option exercise 10b5-1 | +9,991 | 81,005 | ||
| 2026-04-07 | Patel Sanj K CHAIRMAN & CEO | Shares withheld for taxes 10b5-1 | −4,831 | $48.94 | $236K | 76,174 |
| 2026-04-07 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Restricted Share Unit 10b5-1 | −9,991 | 0 | ||
| 2026-04-07 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise | +3,932 | $1.00 | $4K | 35,709 |
| 2026-04-07 | Megna Michael R CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −1,666 | $48.94 | $82K | 34,043 |
Page 13 of 74 · 1,467 trades